Abstract
The role of amyloid metabolism in the pathophysiology of frontotemporal lobar degeneration (FTLD) has yet to be elucidated. We compared CSF levels of amyloid beta 1-40 (AP40) and amyloid beta 1-42 (Aβ42) in patients with FTLD (n = 21) versus patients with Alzheimer's disease (AD, n = 39) and in control subjects (n = 30). While in AD cases Aβ42 levels were lower and CSF Aβ40 levels equal to those in controls, a significant decrease in Aβ40 and increase in the CSF Aβ42/ Aβ40 ratio was observed in FTLD compared with AD and control subjects. These findings favour a differential involvement of amyloid β peptides in FTLD compared with AD.
Original language | English |
---|---|
Pages (from-to) | 735-737 |
Number of pages | 3 |
Journal | Journal of Neurology, Neurosurgery and Psychiatry |
Volume | 78 |
Issue number | 7 |
DOIs | |
Publication status | Published - 1 Jul 2007 |